ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Steven R. Gundry
Anees J. Razzouk
Leonard L. Bailey
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Checchia, P. A.
Right arrow Articles by Bailey, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Checchia, P. A.
Right arrow Articles by Bailey, L. L.
Related Collections
Right arrow Congenital - cyanotic

Ann Thorac Surg 2004;77:477-483
© 2004 The Society of Thoracic Surgeons


Original article: cardiovascular

Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome

Paul A. Checchia, MD, FAAPa*, Ranae Larsen, MDb, Ruchir Sehra, MDb, Noha Daher, PhDc, Steven R. Gundry, MD, FAAPd, Anees J. Razzouk, MDd, Leonard L. Bailey, MDd

a Department of Critical Care Medicine, Loma Linda University Children's Hospital, Loma Linda, California, USA
b Department of Cardiology, Loma Linda University Children's Hospital, Loma Linda, California, USA
d Department of Cardiothoracic Surgery, Departments of Pediatrics and Surgery, Loma Linda University Children's Hospital, Loma Linda, California, USA
c School of Allied Health Professionals, Loma Linda University, Loma Linda, California, USA

Accepted for publication August 6, 2003.

* Address reprint requests to Dr Checchia, Washington University School of Medicine, St. Louis Children's Hospital, Campus Box 8116, One Children's Place, Suite 5S20, St. Louis, MO 63110, USA
e-mail: checchia_p{at}kids.wustl.edu


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
BACKGROUND: We report the development and implementation of a program designed to assign patients preoperatively to either transplant or Norwood procedure based on a score derived from known risk factors and to enhance postoperative care of infants undergoing the Norwood procedure.

METHODS: A weighted score for each of six variables comprised the scoring system: ventricular function, tricuspid regurgitation, ascending aortic diameter, atrial septal defect blood flow characteristics, blood type, and age. The scoring system was used to prospectively assign mortality risk and lead to recommendation of either Norwood procedure or transplantation.

RESULTS: Survival following the Norwood procedure significantly improved after the management program was implemented (88% versus 40% at 48 hours, 57% versus 10% at 30 days, and 50% versus 10% at 1 year, p < 0.0001 at each time point). The survival of the group that received a score of 7 or less (high risk) who underwent the Norwood procedure was 78% at 48 hours, 44% at 30 days, and 33% at 1 year; survival rates among patients considered lower risk (greater than 7) were 100% at 48 hours and 80% at 30 days and 1 year. Transplant outcomes remained unchanged.

CONCLUSIONS: We report improved survival following the Norwood procedure after the implementation of an institutional management approach aimed at improving the outcome of infants with hypoplastic left heart syndrome and may help neutralize historical biases toward Norwood procedure or transplantation.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Hypoplastic left heart syndrome (HLHS) refers to a constellation of congenital cardiac anomalies characterized by marked hypoplasia or absence of the left ventricle and severe hypoplasia of the ascending aorta. Without surgical intervention, HLHS is fatal, accounting for 25% of cardiac deaths during the first week of life. Historically, HLHS has been managed using one of two distinct pathways: transplant or surgical palliation. Despite dramatic improvements in staged reconstructive approaches in recent years, perioperative mortality and morbidity associated with the stage I palliation of HLHS (Norwood procedure) remains generally excessive [1]. Attempts have been made to improve outcome of stage I reconstruction through improved patient selection and postoperative care based on anatomic and physiologic factors [29]. However, no one set of characteristics has been consistently predictive of better outcomes. Rather, these improved outcomes have been largely reflective of the commitment and efforts of individual centers, their surgeons, anesthesiologists, intensivists, nurses, and other key personnel.

Loma Linda University Children's Hospital (LLUCH) has favored transplantation to manage HLHS [10]; however, diminished availability of organs and reports of improved survival after surgical palliation [11, 12] led to a reexamination of this institutional transplantation bias. We evaluated our approach to HLHS with the primary goal of improving the outcomes of transplantation and palliative reconstruction. This evaluation led to the development of a program, the goal of which was to assign patients preoperatively to either transplant or surgical palliation based on known risk factors, and to enhance postoperative care of infants having stage I reconstruction. We anticipated that the protocol would limit the total number of infants with HLHS awaiting transplantation to only infants in whom findings suggested significantly increased risks if they were to be managed by palliative reconstruction. We also hoped the protocol would ensure commitment to care and outcomes that would be independent of the surgical strategy used. The purpose of the current study was twofold: to examine the effect of the protocol on improving outcome of patients with HLHS and to identify the specific factors responsible for that outcome.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
An institutional commitment to maximize favorable outcomes in patients with HLHS led to the implementation of a preoperative risk assessment scoring system and management protocol based on available evidence on outcomes in patients with HLHS. The program was developed through cooperation of a team composed of cardiologists, cardiac surgeons, cardiac intensivists, neonatologists, nurses, and others. Implementation of the program began in August 1999. This report provides results from inception of the program until April 2002. The program group was compared with an historical control group of patients with HLHS cared for at Loma Linda University from January 1, 1997, to the date of implementation of the program on August 1, 1999.

Study population
We included all patients with the diagnosis of HLHS, which was defined as concordant atrioventricular and ventriculoarterial connections and either aortic valve atresia or stenosis. Patients were excluded only if surgical intervention was performed at another institution before referral.

Scoring system
A weighted score for each of six factors comprised the scoring system. Factors included ventricular function, tricuspid regurgitation, ascending aortic diameter, atrial septal defect blood flow characteristics, blood type, and age. The scoring system was weighted to reflect the relative importance of each factor based on group consensus interpretation of available data. The echocardiogram immediately preceding surgery was used for evaluation and scoring.

The scoring system is outlined in Table 1. Ventricular dysfunction was determined by a qualitative assessment of right ventricular ejection fraction. Function was evaluated as good if the ejection fraction was higher than 40%, marginal if 30% to 40%, and poor if less than 30%. Tricuspid regurgitation was assigned to be either moderate or severe. Moderate tricuspid regurgitation was defined as extension of the regurgitant jet to the back of the right atrium by color Doppler, or more than 25% of right atrial area in the plane in which the color Doppler tricuspid regurgitation jet was the greatest. Severe tricuspid regurgitation was defined as extension of the regurgitant jet to the back of the right atrium and more than 50% of right atrial area in the plane in which the color Doppler tricuspid regurgitation jet was the greatest. The ascending aortic size was measured just distal to the valve annulus. The atrial septal defect was deemed restrictive if the mean flow velocity across the defect was measured at more than 1.5 m/s with lack of variability in flow velocity. Blood type was considered because of its effect on organ availability and wait list time. Age at surgery was considered a factor to control for the practice of offering the Norwood procedure only after perceived excessive transplant wait times.


View this table:
[in this window]
[in a new window]
 
Table 1. Preoperative Scoring System

 
The team caring for these patients prospectively decided that a score of more than 7 would indicate lower reconstructive mortality risk; therefore palliation with the Norwood procedure was recommended. A total score of 7 points or less indicated a higher risk of mortality after the Norwood procedure, thus cardiac transplantation would be recommended. While these were the recommendations of the physicians involved, the parents or guardians of the children made the final treatment decision.

Surgical management
No significant change was made in the well-established surgical and perioperative protocols for infants who received cardiac transplantation. The technique of orthotopic cardiac transplantation for HLHS has been described previously [13].

The modified Norwood reconstruction consisted of mobilization of the descending aorta, excision of all ductal tissue, and reconstruction of the neoaorta using native hypoplastic ascending aorta and arch augmented by pulmonary artery trunk and immobilized ascending aortic tissue. The right and left pulmonary artery continuity was achieved with autologous pericardial patch.

Infants in whom hemodynamic stability was maintained during the manipulation and dissection of the innominate artery had the construction of the shunt-innominate artery and anastomosis done first. The shunt was then used as the site for arterial systemic perfusion. Otherwise, the arterial cannula was placed into the patent ductus arteriosus and the shunt was constructed later during cardiopulmonary bypass.

Cardiopulmonary bypass was established using arterial cannulation of the ductus arteriosus through the main pulmonary artery and a single venous cannula in the right atrium. The pump circuit was primed with crystalloid solution that resulted in hemodilution (hematocrit of approximately 8% to 10%) during the cooling phase and period of reconstruction. Patients were cooled to a rectal temperature of 20°C. Once on bypass, the ductus was snared around the cannula, directing all blood to the aorta, and the main pulmonary artery was transected obliquely just proximal to its bifurcation. The confluence of the right and left pulmonary arteries was augmented with untreated autologous pericardium. The arterial cannula was then inverted, the distal right and left pulmonary arteries snared, and arterial flow was delivered retrogradely through the Blalock-Taussig shunt into the innominate artery. The ductus was ligated and excised from the isthmus of the aorta. The left carotid and subclavian vessels were occluded with snares and the descending aorta was clamped. A single dose of blood cardioplegia was delivered if the ascending aorta was used in reconstruction; otherwise, the reverse blood flow through the shunt was maintained, perfusing the innominate artery and ascending aorta.

The undersurface of the aortic arch was opened and the arch was reconstructed using the mobilized descending aorta and main pulmonary artery. Atrial septectomy was performed under low-flow sucker-bypass. The neoaorta was cannulated for arterial inflow, and full cardiopulmonary bypass was reinstituted, followed by rewarming, ultrafiltration, and hemoconcentration. Ultrafiltration and hemoconcentration were performed during the rewarming and reperfusion phase. Infants were weaned off cardiopulmonary bypass with a hematocrit of 30% to 36%. The oximetric catheter was placed in the superior vena cava and directed cephalad to the jugular vein. All patients left the operating room with an open sternotomy, covered with Betadine-impregnated plastic sheeting.

Postoperative monitoring
Each patient was cared for and monitored using routine intensive care practices for the LLUCH pediatric cardiac intensive care unit. These included central venous catheter placement, central venous pressure monitoring, and arterial blood pressure monitoring. In addition, a 4F oximetric catheter (4F OxyCath; Abbott Laboratories, North Chicago, IL) was placed in the superior vena cava to allow continuous monitoring of estimated mixed venous oxygen saturation (SvO2). The oximetric catheter was placed intraoperatively and calibrated in the operating room. If the surgeon was unable to place oximetric catheter during surgery or if the catheter failed to function properly during the initial 48 hours after surgery, simultaneous arterial and central venous blood gas measurements were obtained hourly for the first 24 hours and every 2 hours for the next 24 hours.

Postoperative protocol
The postoperative management protocol included delayed sternal closure, continuous mixed venous saturation measurements, and calculation of the ratio of pulmonary to systemic blood flow (Qp/Qs), AVO2 difference, and oxygen extraction ratio computed by the bedside nurse (see Appendix). Postoperative management centered on maximizing SvO2, and circulatory balance was estimated using the Fick equation. Interventions were recommended based on the protocol and the protocol extended throughout the first 48 hours after operation (Table 2). Final clinical decisions were made by either the attending surgeon or cardiac intensivist caring for the patient.


View this table:
[in this window]
[in a new window]
 
Table 2. Postoperative Protocol

 
Follow-up
Our protocol during the follow-up period of 1 year has included standard outpatient cardiology surveillance. Patients were maintained on afterload reduction with an angiotensin-converting enzyme and myocardial support with digoxin. Additionally, patients received diuretic therapy. Patients were weaned off diuretic therapy if their right ventricular function was normal and if they were clinically stable without signs or symptoms of congestive heart failure. Patients were recommended to proceed to a Glenn shunt between 6 and 9 months of age.

Statistical analysis
Descriptive statistics were used to summarize the data. A Z-test was conducted to compare the survival rate between the historical control group and the management program group. Conditional logistic regression analysis was done to evaluate the influence of individual factors on survival. All analyses were conducted with the use of statistical software SAS version 8 (SAS Institute, Cary, NC).


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
The management program was implemented on August 1, 1999. From August 1, 1999, to January 1, 2002, 18 patients with HLHS were referred to LLUCH for treatment. This group was compared with an historical control group of 21 patients cared for at LLUCH for HLHS from January 1, 1997, to August 1, 1999. Eleven patients in the historical control group received transplants and 10 underwent the Norwood procedure. Following the implementation of the management program, 4 patients received transplants and 14 underwent the Norwood procedure.

To determine the effect of the management program on short-, intermediate-, and long-term survival, comparisons of postoperative mortality were made at 48 hours, 30 days, and 1 year after initial treatment. Survival among HLHS patients who underwent the Norwood procedure significantly improved after the implementation of the management program when compared with the historical control group (Fig 1). This improvement was noted at the three time points measured (88% versus 40% at 48 hours, 57% versus 10% at 30 days, and 50% versus 10% at 1 year, p < 0.0001 at each time point).



View larger version (22K):
[in this window]
[in a new window]
 
Fig 1. Effect of management program on survival (%) of patients who underwent the Norwood procedure. Hatched bar, no protocol (N = 10); solid bar, protocol (N = 14). *p < 0.0001 at each time point.

 
Survival among HLHS patients who underwent transplantation did not change between the two groups. The historical control group had a survival of 100% at 48 hours, 82% (9 of 11 patients) at 30 days, and 73% (8 of 11 patients) at 1 year. Survival of patients (n = 4) who underwent transplantation after the initiation of the HLHS management program was 100% at 48 hours and 75% at 30 days and 1 year. A total of 29 HLHS patients were listed for transplantation (8 after initiation of the HLHS management program). The mortality on the transplant list did not change between the two groups: the rate was 24% for the historical control group compared with 25% for the management program group.

The management program group consisted of 18 patients; each was assigned a preoperative score from which an operative pathway was recommended. Twelve patients received a score of 7 or less and were considered to be at higher complication risk for the Norwood procedure, leading to the recommendation for transplant. Despite the institutional recommendation, only 3 families opted for transplantation and the remaining 9 underwent the Norwood procedure. Survival rates among the 3 transplanted patients from the high-risk Norwood group was 100% at 48 hours and 66% at 30 days and 1 year. Survival among the 9 patients who received a score of 7 or less who underwent the Norwood procedure was 78% at 48 hours, 44% at 30 days, and 33% at 1 year. Six patients received a A-vo2 difference, and score of more than 7 and were considered lower risk candidates for the Norwood procedure. Five of these 6 patients (the low-risk Norwood group) underwent the Norwood procedure and survival rates were 100% at 48 hours and 80% at 30 days and 1 year (Fig 2). The sixth patient had transplantation and was alive after 1 year of follow-up. Statistical comparisons did not yield significant results due to the limited population size.



View larger version (10K):
[in this window]
[in a new window]
 
Fig 2. Survival of patients who underwent the Norwood procedure based on total score. Dashed line indicates low-risk score (> 7) (n = 7); solid line, high risk score (<= 7) (n = 17). p = NS.

 
One surgeon performed most of the Norwood procedures: 88% (21 of 24 patients) throughout the historical period and after the implementation of the initiative. Furthermore, the management program included the addition of full-time attending physician coverage by a pediatric cardiac intensivist. The postoperative protocol relied on hourly nursing calculation and interpretation of Qp/Qs and AVO2 differences. These calculations were performed correctly and timely in more than 96% of instances.

Logistic regression analysis was performed on each group as well as the population as a whole to evaluate the effect of individual factors on the increased survival. The use of the postoperative protocol significantly increased survival at 48 hours (odds ratio [OR], 8.99; confidence interval [CI], 1.27 to 63.88; p = 0.03) and 30 days (OR, 12.0; CI, 1.18 to 122.27; p = 0.03). Logistic analysis of individual factors of the scoring system did not reveal any single factor that predicted survival.


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
Our study demonstrates increased survival of patients following the Norwood procedure for HLHS during implementation of an institutional management program. The management program included standardized preoperative candidate selection and perioperative care. Evolution of management of the infant with HLHS has centered on two pathways—either transplantation or the Norwood procedure. We sought to offer both options without bias, anticipating competitive outcomes. We hypothesized that a specific population of patients may have a higher mortality risk despite excellent surgical technique and postoperative care because of factors that could be assessed preoperatively.

Several investigators have attempted to identify patients at highest risk for death after the Norwood procedure [3, 7, 8, 1418]. They sought to improve outcomes by implementing postoperative treatment protocols. These protocols have demonstrated improved survival utilizing SvO2 monitoring [19, 20], inotropic support [21], or a combination of approaches [2]. Our approach is unique, as preoperative decisions did not depend on an individual variable. Instead, we have combined elements from each strategy to develop a selection process to provide for the highest chance of success with a protocol that optimizes postoperative treatment.

Selection of appropriate candidates for the Norwood procedure is multifactorial. Indeed, our analysis suggests that no single variable was more important than another in the preoperative decision algorithm. The variables chosen were based on published reports available at the time of initiation of our protocol, as well as institutional experience. Our group sought to incorporate anatomic, physiologic, and logistic factors into a single, weighted scoring system. One of the stronger associations with increased mortality after the Norwood procedure is the diameter of the ascending aortic arch [8, 12, 18, 22]. Thus, the scoring system was weighted more heavily for this factor. It has been the experience in our institution and among others, that greater postnatal age is associated with higher Norwood procedure mortality [2325]. Finally, to account for organ availability, the longer waiting time for patients with blood type O was accounted for in the scoring system.

Preoperative ventricular dysfunction has been associated with increased incidence of postoperative complications in children who have undergone the Norwood procedure [14]. While ventricular dysfunction has a detrimental effect on survival following Norwood palliation, the condition does not appear to jeopardize survival during the wait for heart transplantation. Consequently, the presence of preoperative ventricular dysfunction shifts our management recommendation toward transplant. Similarly, the presence of a restrictive atrial septal defect [26] and clinically relevant tricuspid regurgitation has been reported as risk factors for mortality after Norwood reconstruction [6, 22]. Hence, presence of these variables tends to shift the decision score toward transplantation.

The postoperative protocol incorporates many of the strategies supported by several recent investigations. A goal-directed approach using constant SvO2 monitoring [2, 1921], milrinone [21], and delayed sternal closure [27] was used. The relative contribution of each of these components is unknown in our population. However, Tweddell and associates [2] have recently reported their experience with the additive effect of each of the various postoperative components. We believe that the use of SvO2 monitoring and bedside nurse calculations of AVO2 differences allowed earlier anticipation of deterioration of clinical status. Furthermore, the use of milrinone may be beneficial in reducing the severity of low cardiac output syndrome during the first 48 hours after the operation [28]. One other possibility is that because our data showed that more than 96% of nursing assessments were completed on time, the management program may have had an unexpected benefit in improving nursing diligence by providing the bedside nurse with a template of physiologic variables unique to the Norwood patient.

The inability to correlate survival improvement to individual components of the management approach, both preoperatively and postoperatively, represents a limitation of the study. However, we speculate that the individual factors of the preoperative scoring system and the postoperative protocol were less important to our success than the cumulative effects of the entire program.

Our institutional commitment to succeed includes focused, intense nursing education; the addition of a full-time pediatric cardiac intensivist; and scheduling that allowed a single surgeon to perform the vast majority of the procedures. This commitment allowed for greater standardization of care delivered to the patients. We speculate that the implementation of this program at other institutions would have equal impact because our success occurred at an institution that has historically favored transplantation and has previously had limited experience and success with the Norwood procedure.

In conclusion, we report the implementation of an institutional management approach aimed at improving the outcome of infants with HLHS. Survival improved in patients undergoing surgical palliation with the Norwood procedure at an institution historically favoring transplantation. This accomplishment represented a significant paradigm shift for the institution. The reproducibility of our success using this management program at institutions already committed to staged surgical palliation remains unknown.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 
We are indebted to John K. McGuire, MD, and Ronald Bronicki, MD, for their assistance in the preparation of the manuscript; to our colleagues Ann Totaro, RN, Jolanda Jones, RN, and Eileen Fry-Bowers, RN, CNP; and to the nurses and staff members of the Pediatric Cardiac Intensive Care Unit at LLUCH.


    Appendix
 
Formulas
AVo2=Sao2-Svo2

AVO2 = arteriovenous oxygen saturation; OER = oxygen extraction ratio; Qp/Qs = ratio of pulmonary to systemic blood flow; SaO2 = arterial oxygen saturation; SvO2 = mixed venous oxygen saturation.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Pearl J.M., Nelson D.P., Schwartz S.M., Manning P.B. First-stage palliation for hypoplastic left heart syndrome in the twenty-first century. Ann Thorac Surg 2002;73:331-340.[Abstract/Free Full Text]
  2. Tweddell J.S., Hoffman G.M., Mussatto K.A., et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome. Lessons learned from 115 consecutive patients. Circulation 2002;106(Suppl I):I82-89.
  3. Bove E.L., Lloyd T.R. Staged reconstruction for hypoplastic left heart syndrome. Contemporary results. Ann Surg 1996;224:387-395.[Medline]
  4. Azakie T., Merklinger S.L., McCrindle B.W., et al. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg 2001;72:1349-1353.[Abstract/Free Full Text]
  5. Bando K., Turrentine M.W., Sun K., et al. Surgical management of hypoplastic left heart syndrome. Ann Thorac Surg 1996;62:70-77.[Abstract/Free Full Text]
  6. Hehrlein F.W., Yamamoto T., Orime Y., Bauer J. Hypoplastic left heart syndrome: "which is the best operative strategy". Ann Thorac Cardiovasc Surg 1998;4:125-132.[Medline]
  7. Iannettoni M.D., Bove E.L., Mosca R.S., et al. Improving results with first-stage palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994;107:934-940.[Abstract/Free Full Text]
  8. Jonas R.A., Hansen D.D., Cook N., Wessel D. Anatomic subtype and survival after reconstructive operation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1994;107:1121-1128.[Abstract/Free Full Text]
  9. Poirier N.C., Drummond-Webb J.J., Hisamochi K., Imamura M., Harrison A.M., Mee R.B. Modified Norwood procedure with a high-flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction. J Thorac Cardiovasc Surg 2000;120:875-884.[Abstract/Free Full Text]
  10. Bailey L.L., Nehlsen-Cannarella S.L., Doroshow R.W., et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med 1986;315:949-951.[Medline]
  11. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant 2001;20:805-815.[Medline]
  12. Bove E.L. Current status of staged reconstruction for hypoplastic left heart syndrome. Pediatr Cardiol 1998;19:308-315.[Medline]
  13. Vricella L.A., Razzouk A.J., del Rio M., Gundry S.R., Bailey L.L. Heart transplantation for hypoplastic left heart syndrome: modified technique for reducing circulatory arrest time. J Heart Lung Transplant 1998;17:1167-1171.[Medline]
  14. Andrews R., Tulloh R., Sharland G., et al. Outcome of staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis. Arch Dis Child 2001;85:474-477.[Abstract/Free Full Text]
  15. Drinkwater D.C., Jr, Aharon A.S., Quisling S.V., et al. Modified Norwood operation for hypoplastic left heart syndrome. Ann Thorac Surg 2001;72:2081-2087.[Abstract/Free Full Text]
  16. Imoto Y., Kado H., Shiokawa Y., Minami K., Yasui H. Experience with the Norwood procedure without circulatory arrest. J Thorac Cardiovasc Surg 2001;122:879-882.[Abstract/Free Full Text]
  17. Jonas R.A., Lang P., Hansen D., Hickey P., Castaneda A.R. First-stage palliation of hypoplastic left heart syndrome. The importance of coarctation and shunt size. J Thorac Cardiovasc Surg 1986;92:6-13.[Abstract]
  18. Lofland G.K., McCrindle B.W., Williams W.G., et al. Critical aortic stenosis in the neonate: a multi-institutional study of management, outcomes, and risk factors. Congenital Heart Surgeons Society. J Thorac Cardiovasc Surg 2001;121:10-27.
  19. Hoffman G.M., Ghanayem N.S., Kampine J.M., et al. Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome. Ann Thorac Surg 2000;70:1515-1521.[Abstract/Free Full Text]
  20. Rossi A.F., Sommer R.J., Lotvin A., et al. Usefulness of intermittent monitoring of mixed venous oxygen saturation after stage I palliation for hypoplastic left heart syndrome. Am J Cardiol 1994;73:1118-1123.[Medline]
  21. Reinoso-Barbero F., Garcia-Fernandez F.J., Diez-Labajo A., del Cerro M.J., Cordovilla G. Postoperative use of milrinone for Norwood procedure. Paediatr Anaesth 1996;6:342-343.[Medline]
  22. Bartram U., Grunenfelder J., Van Praagh R. Causes of death after the modified Norwood procedure: a study of 122 postmortem cases. Ann Thorac Surg 1997;64:1795-1802.[Abstract/Free Full Text]
  23. Mahle W.T., Spray T.L., Wernovsky G., Gaynor J.W., Clark B.J., III Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000;102(Suppl III):III136-141.
  24. Duncan B.W., Rosenthal G.L., Jones T.K., Lupinetti F.M. First-stage palliation of complex univentricular cardiac anomalies in older infants. Ann Thorac Surg 2001;72:2077-2080.[Abstract/Free Full Text]
  25. Rossi A.F., Sommer R.J., Steinberg L.G., et al. Effect of older age on outcome for stage one palliation of hypoplastic left heart syndrome. Am J Cardiol 1996;77:319-321.[Medline]
  26. Graziano J.N., Heidelberger K.P., Ensing G.J., Gomez C.A., Ludomirsky A. The influence of a restrictive atrial septal defect on pulmonary vascular morphology in patients with hypoplastic left heart syndrome. Pediatr Cardiol 2002;23:146-151.[Medline]
  27. Tabbutt S., Duncan B.W., McLaughlin D., Wessel D.L., Jonas R.A., Laussen P.C. Delayed sternal closure after cardiac operations in a pediatric population. J Thorac Cardiovasc Surg 1997;113:886-893.[Abstract/Free Full Text]
  28. Hoffman T.M., Wernovsky G., Atz A.M., et al. Efficacy, and safety of milrinone in preventing low cardiac output syndrome in infants, and children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. A. Hehir, T. E. Dominguez, J. A. Ballweg, C. Ravishankar, B. S. Marino, G. L. Bird, S. C. Nicolson, T. L. Spray, J. W. Gaynor, and S. Tabbutt
Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 94 - 99.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
B. Alsoufi, T. Karamlou, B. W. McCrindle, and C. A. Caldarone
Management options in neonates and infants with critical left ventricular outflow tract obstruction
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. S. Sundareswaran, K. R. Kanter, H. D. Kitajima, R. Krishnankutty, J. F. Sabatier, W. J. Parks, S. Sharma, A. P. Yoganathan, and M. Fogel
Impaired power output and cardiac index with hypoplastic left heart syndrome: a magnetic resonance imaging study.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1267 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sinzobahamvya, J. Photiadis, D. Kumpikaite, C. Fink, H. C. Blaschczok, A. M. Brecher, and B. Asfour
Comprehensive aristotle score: implications for the norwood procedure.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1794 - 1800.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. G. Berry, C. G. Cowley, C. J. Hoff, and R. Srivastava
In-Hospital Mortality for Children With Hypoplastic Left Heart Syndrome After Stage I Surgical Palliation: Teaching Versus Nonteaching Hospitals
Pediatrics, April 1, 2006; 117(4): 1307 - 1313.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. A. Bacha, S. Daves, J. Hardin, R.-i. Abdulla, J. Anderson, M. Kahana, P. Koenig, B. N. Mora, M. Gulecyuz, J. P. Starr, et al.
Single-ventricle palliation for high-risk neonates: The emergence of an alternative hybrid stage I strategy
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 163 - 171.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Tabbutt, T. E. Dominguez, C. Ravishankar, B. S. Marino, P. J. Gruber, G. Wernovsky, J. W. Gaynor, S. C. Nicolson, and T. L. Spray
Outcomes After the Stage I Reconstruction Comparing the Right Ventricular to Pulmonary Artery Conduit With the Modified Blalock Taussig Shunt
Ann. Thorac. Surg., November 1, 2005; 80(5): 1582 - 1591.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. A. Checchia, J. McCollegan, N. Daher, N. Kolovos, F. Levy, and B. Markovitz
The effect of surgical case volume on outcome after the Norwood procedure
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 754 - 759.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Rellensmann, T. Krasemann, and H.-G. Kehl
Should All Stage-One Norwood Patients Receive a Prolonged Period of Postoperative Mechanical Circulatory Support?
Ann. Thorac. Surg., March 1, 2005; 79(3): 1098 - 1099.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Steven R. Gundry
Anees J. Razzouk
Leonard L. Bailey
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Checchia, P. A.
Right arrow Articles by Bailey, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Checchia, P. A.
Right arrow Articles by Bailey, L. L.
Related Collections
Right arrow Congenital - cyanotic


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS